Aug 2026· International ophtalmology· Vol 46· 0 citations· 39 references
Medicine
TL;DR
AR(1) provides superior pointwise prediction accuracy, particularly in advanced glaucoma, while HFA-MD predictions are generally comparable among AR(1), OLR, and exponential approaches.
Visual field testing is essential for detecting glaucomatous damage. Traditional approaches such as pointwise linear regression often fail to account for the spatial correlations and hierarchical structure among test locations. We propose a two-fold linear mixed model that incorporates both eye-level and within-eye clu...
Chen Zhao, S. Swaminathan, J. S. Rao· Journal of Statistical Theor...· 0 citations
GLAM (Glaucoma Longitudinal Analysis Model), a deep learning framework that ingests longitudinal Humphrey 24-2 total deviation sequences with five clinical features and predicts MD and visual field index progression rates using attention-based fusion and aleatoric uncertainty, is presented.
Taiabur Rahman, Siddiqur Rahman, M. Moniruzzaman et al.· arXiv.org· 0 citations
A model integrating corneal biomechanical parameters, genetic risk scores, and tear molecular biomarkers was developed to predict the risk of NTG progression and demonstrated potential clinical utility.
BACKGROUND/AIMS
To determine whether baseline central visual field defect (CVFD) distribution and archetypal 10-2 patterns are associated with subsequent central visual field (VF) progression in glaucoma.
METHODS
This retrospective multicentre longitudinal cohort included 127 eyes of 94 adults with glaucoma, baseline...
Euido Nishijima, Kei Sano, Yuka Igari et al.· British Journal of Ophthalmo...· 0 citations
Vision in this cohort was largely set by the state of the eye at diagnosis, and IOP control and pain relief therefore remain realistic goals even when sight cannot be saved.
G. Simons, M. von Fersen, A. Dahlberg et al.· medRxiv· 0 citations
In eyes with ODD, thinner RNFL and worse VF MD at baseline are associated with a higher risk of moderate–fast VF decline, supporting risk-stratified monitoring regardless of glaucoma label or IOP.
Rohit Reddy, Rong-Rui Liu, W. Shalaby et al.· International ophtalmology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.